Related Experiment Videos
Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferon in vitro
Abstract:
The production of gamma interferon (IFN) by mononuclear cells (MNC) from patients with exacerbating/remitting multiple sclerosis (MS) and controls was evaluated. After 3 days of culture with concanavalin A, the amount of gamma IFN in supernatant fluids was determined by radioimmunoassay. MNC from MS patients produced significantly (P less than 0.001) more gamma IFN than MNC from either normal controls or patients with other neurologic diseases. Levels of gamma IFN in the serum and CSF were also measured. Despite the relative absence of gamma IFN in serum (4 positive of 30), all CSF samples tested had low, but detectable, levels of gamma IFN (0.3 to 1.4 U/ml). These studies suggest that some of the autoimmune features and immunologic abnormalities in MS may be related to elevated gamma IFN production.
Insights
Patients with multiple sclerosis (MS) show elevated production of gamma interferon (IFN) from mononuclear cells (MNC). This finding suggests a link between increased gamma interferon and the autoimmune aspects of MS.
Area of Science:
- Immunology
- Neuroscience
- Cell Biology
Background:
- Multiple Sclerosis (MS) is an autoimmune disease affecting the central nervous system.
- Immunological abnormalities are implicated in the pathogenesis of MS.
- Gamma interferon (IFN) is a cytokine with a key role in immune responses.
Purpose of the Study:
- To evaluate gamma interferon (IFN) production by mononuclear cells (MNC) in patients with relapsing-remitting multiple sclerosis (MS).
- To compare IFN production in MS patients with healthy controls and patients with other neurological diseases.
- To investigate the presence of gamma IFN in serum and cerebrospinal fluid (CSF) of MS patients.
Main Methods:
- Mononuclear cells (MNC) were isolated from patients with MS, other neurological diseases, and healthy controls.
- MNC were cultured for 3 days with concanavalin A.
- Gamma interferon (IFN) levels in culture supernatants, serum, and CSF were quantified using radioimmunoassay.
Main Results:
- MNC from MS patients produced significantly higher levels of gamma IFN compared to controls (P < 0.001).
- Elevated gamma IFN production was specific to MS patients, not observed in patients with other neurological conditions.
- While serum showed minimal gamma IFN, cerebrospinal fluid (CSF) consistently contained detectable levels in MS patients.
Conclusions:
- The study indicates elevated gamma interferon (IFN) production in patients with multiple sclerosis (MS).
- Increased gamma IFN may contribute to the autoimmune processes and immunological dysregulation observed in MS.
- Gamma interferon (IFN) in CSF warrants further investigation as a potential biomarker or contributor to MS pathology.